DADD, death activator death domain protein

Details DADD, death activator death domain protein DADD, death activator death domain protein

2005-05-13

2009-08-18

Helms, Larry R. (Department: 1643)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S387900

Reexamination Certificate

active

07576178

ABSTRACT:
Polynucleotides encoding DADD protein are also disclosed, along with vectors, host cells, and methods of making DADD protein. Methods of identifying inhibitors of DADD death domain binding and inhibitors identified by such methods are also disclosed.

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4518584 (1985-05-01), Mark et al.
patent: 4737323 (1988-04-01), Martin et al.
patent: 4837028 (1989-06-01), Allen
patent: 5296592 (1994-03-01), Dower et al.
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5614396 (1997-03-01), Bradley et al.
patent: 5616491 (1997-04-01), Mak et al.
patent: 5627059 (1997-05-01), Capecchi et al.
patent: 5631153 (1997-05-01), Capecchi et al.
patent: 5679523 (1997-10-01), Li et al.
patent: 308378 (1989-03-01), None
patent: 393438 (1990-10-01), None
patent: 433900 (1991-06-01), None
patent: 526905 (1993-02-01), None
patent: 568925 (1993-11-01), None
patent: 649464 (1995-04-01), None
patent: WO 91/03553 (1991-03-01), None
patent: WO 93/19777 (1993-10-01), None
patent: WO 96/36730 (1996-11-01), None
US 5,843,791, 12/1998, Hauptmann et al. (withdrawn)
Vincent TK, Chow KM, Daniel L. Genome, 41: 543-552, 1998.
Albert et al.Trends Pharmacol. Sci., 15(7):250-254 (1994).
Ausubel et al.Curr. Prot. Mol. Biol., pp. 16.7.1.-16.7.8 (1990).
Chinnaiyan et al.Cell, 81:505-512 (1995).
Chinnaiyan et al.Science, 274:990-992 (1996).
Clark et al.Proc Natl. Acad. Sci. USA, 91(2):719-722 (1994).
Eck et al.Gene-Based Therapy, in “The Pharmacological Basis of Therapeutics”, Goodman and Gilman, Eds., pp. 77-101 (1996).
Genbank Accession No. R13288 (Apr. 12, 1995).
Genbank Accession No. N39432 (Jan. 19, 1996).
Genbank Accession No. N50632 (Feb. 14, 1996).
Genbank Accession No. N55392 (Feb. 20, 1996).
Genbank Accession No. AA118566 (Nov. 19, 1996).
Genbank Accession No. AA507436 (Aug. 18, 1997).
Genbank Accession No. AA631067 (Oct. 31, 1997).
Genbank Accession No. AA642327 (Nov. 13, 1997).
Genbank Accession No. AA714504 (Dec. 29, 1997).
Genbank Accession No. AA1022161.
HampelProg. Nucl. Acid Res. Mol. Biol., 58:1-39 (1998).
HoudebineJ. Biotechnol., 34:269-287 (1994).
Hsu et al.Cell, 81:495-504 (1995).
Lavrovsky et al.Biochem. Mol. Med., 62(1):11-22 (1997).
LehningenBiochem., Worth Publishers, Inc., New York, NT, p. 962 (1975).
Mansour et al.Nature, 336:348-352 (1988).
Orkin et al “Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”,NIH(1995).
Pan et al.Science, 276:111-113 (1997).
PlasterkBioassays, 14(9):629-633 (1992).
Schall et al.Cell, 61:361-370 (1990).
Schievelia et al.J. Biol. Chem., 272(18):12063-12075 (1997).
Stanger et al.Cell,81:513-523 (1995).
Tartaglia et al.Cell, 74:845-853 (1993).
Verma et al.Nature, 389:239-242 (1997).
Zwaal et al.Proc. Natl. Acad. Sci. USA, 90(16):7431-7435 (1993).

Affiliated with

Also associated with

Rating

DADD, death activator death domain protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DADD, death activator death domain protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DADD, death activator death domain protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4091121